CD274 and neoplasm: In summary, the early data on biomarkers of response to immunotherapy suggest that pretreatment tumor PD-L1 levels, as well as preexisting numbers of CD 8+ T cells and levels of pSTAT1+ cells at the tumor margin may be important predictors of response (Fig. 1).